These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of a single dose of intravenous captopril in hypertensive subjects]. Franchi M; Puccetti F; Landini F; Burresi A; Di Perri T Recenti Prog Med; 1988 Jun; 79(6):261-6. PubMed ID: 2843976 [No Abstract] [Full Text] [Related]
4. [Hypertensive crisis: comparative study of oral captopril, sublingual captopril and sublingual nifedipine]. Martínez Amenós A; Carratalà J; Pintó X; Santaló M; Tamayo C; Pujol M Med Clin (Barc); 1987 Jun; 89(2):59-61. PubMed ID: 3302561 [No Abstract] [Full Text] [Related]
5. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril]. Rosenthal J; Haerlin R Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700 [No Abstract] [Full Text] [Related]
6. Course of blood pressure within the first 12 h of hypertensive urgencies. Hirschl MM; Herkner H; Bur A; Woisetschläger C; Gamper G; Frossard M; Laggner AN J Hypertens; 1998 Feb; 16(2):251-5. PubMed ID: 9535154 [TBL] [Abstract][Full Text] [Related]
7. Overview of clinical trials with urapidil. Schook CE; Radtke H; Wurst W; Thieme G Am J Cardiol; 1989 Aug; 64(7):30D-37D. PubMed ID: 2667312 [TBL] [Abstract][Full Text] [Related]
8. [The antihypertensive effect and the pharmacokinetic profile of captopril retard (CS-522-R) in patients with essential hypertension]. Shionoiri H; Yasuda G; Sugimoto K; Miyazaki N; Miyakawa T; Sesoko S; Kaneko Y Nihon Jinzo Gakkai Shi; 1986 Jan; 28(1):73-8. PubMed ID: 3520062 [No Abstract] [Full Text] [Related]
9. [Clinical experience with an oral converting-enzyme inhibitor (Captopril) in hypertensive subjects]. Pierucci A; Simonetti BM; Feriozzi S; Stirati G; Cinotti GA Minerva Nefrol; 1981; 28(3):271-3. PubMed ID: 7036016 [No Abstract] [Full Text] [Related]
10. [A comparison of the effect of oral captopril and nicardipine in hypertensive crisis]. Addad F; Ferjani H; Chaabani A; Jelliti M; Gamra H; Makni H; Khaldoun BH; Dridi Z; Ben Farhat M Tunis Med; 2008 Feb; 86(2):150-4. PubMed ID: 18444532 [TBL] [Abstract][Full Text] [Related]
11. [Sublingual hypotensive treatment. Does it compare homogeneous groups of hypertensive patients?]. Bonet Sol J; Romero González R; Teixidó Planas J; Caralps Riera A Rev Clin Esp; 1987 Nov; 181(7):403-4. PubMed ID: 3321223 [No Abstract] [Full Text] [Related]
12. [Clinical effects of sublingual captopril in the treatment of hypertensive emergencies]. Lu Y Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Oct; 16(5):268-9, 317. PubMed ID: 3069418 [No Abstract] [Full Text] [Related]
13. [Treatment of hypertensive crisis with sublingual captopril]. Rubio MA; Matamoros P; Guerrero A; Moreno C Rev Clin Esp; 1987 Jan; 180(1):60-1. PubMed ID: 3550931 [No Abstract] [Full Text] [Related]
14. [Inhibition of the antihypertensive activity of intravenous captopril by pretreatment with indomethacin]. Puccetti F; Franchi M; Landini F; Burresi A; Di Perri T Recenti Prog Med; 1988 Jun; 79(6):267-70. PubMed ID: 3047822 [No Abstract] [Full Text] [Related]